Another panelist — Dr. Warris Bokhari, CEO of Claimable — agreed that it should be a qualified human making the decision on ...
In some blood disorders, bone marrow churns out blood cells driving the disease so it makes sense for a drug to go after this source. But bone marrow poses challenges for drug delivery. For a molecule ...
Hone Health, a longevity platform, announced on Wednesday that it has raised $228 million in financing to support its expansion. The direct-to-consumer company offers access to biomarker testing, ...
News emerging during the annual HLTH conference, including ones from Abridge, reflects the growing use of AI in clinical ...
MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed a wide range of healthcare startups ...
Health systems are jumping to integrate AI into clinicians' everyday tools. When those platforms also offer the medical ...
Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli ...
By applying proven and enforceable guardrails, coupled with smart financial incentives, we can ensure AI elevates medical ...
Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The ...
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...
A part-time urgent care doctor who runs healthcare and life sciences projects at Anthropic. as well as other AI experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results